In modern cell therapy, the margin for error is nonexistent. To meet rising demands for scalability, reproducibility, and rigorous patient safety, manufacturers are standardizing on closed-system processing. This evolution away from open manipulation creates a sterile, controlled pathway that protects the integrity of irreplaceable cell products from initial inoculation through long-term storage.

OriGen Biomedical’s quality policy is rooted in one foundational principle: our primary responsibility is to the patients who ultimately receive our products. This commitment drives our focus on closed-system processing, which is designed to protect cell products from inoculation through to cryopreservation.

What is Closed System Processing?

Closed system processing creates a continuous, sealed pathway that eliminates the contamination risks of open manipulations such as pouring, open-pipetting, or manual hood transfers. In cell therapy manufacturing, a closed system is typically achieved through one of two primary connection methods:

1. Luer & Needle-Free Valve (NFV) Configurations

• Swabbable Sampling:  In-process sampling and reagent additions are performed through swabbable, needle-free valves (NFVs). This allows repeated, bi-directional access while maintaining a sterile barrier.
• Luer Lock Transfers: Fluids move securely through standardized luer connections to reduce the risk of accidental disconnects during fluid handling.

2. Tube-Welded (T-Set) Configurations

• Direct Sterile Tube Welding: Designed for cleanrooms that strictly weld lines, T-sets utilize longer tubing to connect directly to manifolds, media bags, or bioreactors via a Sterile Tubing Welder (SCD) without exposing to any internal surfaces.

Why Closed Systems Matter in Cell Therapy

Every time a flask or bottle is opened, the product is exposed to airborne contaminants, mold, and operator error. Closed systems significantly mitigate these risks by replacing open manipulations with a sealed, sterile environment. This directly lowers the potential for contamination and the devastating loss of an entire batch.

Our commitment to quality is reflected in the technical design of the OriGen Biomedical® PermaLife® Cell Culture Bag:

• Material Integrity: The PermaLife bag body is made from fluorinated ethylene propylene (FEP) and contains no plasticizers or phthalates.
• Gas Permeability: The film facilitates gas exchange suitable for cell culture by allowing essential oxygen and CO₂ exchange while remaining water-impermeable, eliminating the need for humidified incubators, a common source of contamination.

Consistency and cGMP Alignment

Scaling from research to clinical manufacturing demands reproducible, auditable processes. Closed systems make that easier by limiting variability from operator technique and room conditions.

PermaLife bags are manufactured under an ISO 13485–certified quality system, are CE-marked and FDA 510(k) – cleared, and are produced in accordance with GMP guidelines that align with the expectations of regulators and quality groups in cell therapy programs. Endotoxin, bioburden, and EtO residuals are routinely monitored and controlled, which helps QA teams qualify the system as part of a validated process.

Operational Efficiency and Training

Closed-system processing standardizes manufacturing workflows by minimizing the need for complex aseptic setups and reducing the frequency of environmental monitoring. For operations teams, this creates a predictable and controlled environment. Needle-free valves and established tubing configurations simplify staff training, as personnel execute required manipulations through validated connection points rather than variable manual transfer methods.

How the PermaLife Bag Enables a True Closed-System Workflow

The PermaLife bag is more than a culture bag; it’s a flexible platform for closed-system processing.

• USP Class VI FEP construction: Pure fluorinated ethylene propylene (FEP) is non-cytotoxic, non-hemolytic biocompatibility (USP Class VI, ISO 10993).
• Gas-permeable FEP film: FEP is gas-permeable, allowing passive diffusion of gases across the film, while its low water vapor transmission rate may help maintain consistent culture volumes and reduce reliance on humidified incubators.
• Needle-free access: Select bags feature swabbable needle-free valves for repeated sterile access, with additional luer or spike ports available for integration with upstream and downstream steps.
• Validated performance: Aging, burst, leak, particulate, and biological safety testing demonstrate reliability over shelf life and across real‑world handling conditions.
• Configurable for your process: Multiple configurations with SCD‑weldable tubing, spike ports, and various tube sets allow you to connect a PermaLife bag into a fully closed system alongside other OriGen Biomedical accessories and freezing bags.

Putting it into Practice: A Day‑in‑the‑Life Workflow

A typical closed PermaLife bag workflow might look like this:

• Inoculation and expansion: Cells are introduced into a PermaLife bag via sterile weld or luer connection, then expanded in an incubator where gas exchange occurs through the FEP film instead of an open cap.
• Feeding and sampling: Media changes and sampling are performed through the needle‑free valve, maintaining a sealed system while providing repeated access.
• Harvest and formulation: The final cell suspension is formulated with cryoprotectant through connected accessories and sterile‑welded tubing, eliminating open mixing steps.
• Cryopreservation and storage: The same PermaLife bag is placed in an O‑Wrap® Bag, then frozen according to validated protocols, and stored down to −196 °C as part of a closed system.

This closed-system workflow not only reduces the risk of contamination and lot loss but also streamlines staff training and documentation, leading to a more consistent and auditable manufacturing pathway. 

A Foundation of Regulatory Excellence

For teams refining their manufacturing workflows, the choice of consumables is a critical quality decision. Every OriGen Biomedical product is manufactured under a robust Quality Management System that aligns with global expectations:

• Global Certifications: Our products are manufactured in a facility that holds ISO 13485:2016 certification and participates in MDSAP, ensuring consistency and regulatory alignment across international markets.
• Validated Performance: PermaLife bags undergo rigorous testing for sterility, integrity, and biological safety, meeting industry benchmarks for patient-facing therapies.
• Traceability: Documentation and lot-level tracking are industry standard, supporting the transparency required by QA teams during audits.

Conclusion

Closed-system processing is an essential requirement for modern cell therapy manufacturing. By adopting validated, industry-preferred solutions like PermaLife bags, organizations may improve operational efficiency, protect irreplaceable autologous and allogeneic products, and ultimately, fulfill the responsibility we share toward the patients who rely on these transformational therapies.

Customers can access product instructions, technical resources, and supporting documentation through the OriGen Biomedical Client Dashboard, and technical references are available through the OriGen Biomedical IFU page, including PermaLife Cell Culture Bags Instructions for Use. 

About the Author

Antonio Domino, MSHGG

Clinical Specialist

Antonio has a Master’s in Human Genetics and Genomics from SCUHS and specializes in translating complex scientific concepts into practical clinical applications. With experience in bioinformatics, cGMP manufacturing, gene-modified cell therapies, and regulatory-aligned workflows, he works closely with clinical and cross-functional teams to support innovative therapies, regulatory excellence, and patient-focused outcomes that advance the future of precision medicine.

View LinkedIn Profile →